Neoplasia/BPH

	Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants. Int J Urol Yasuda Y, Yoshida S, Yonese I, Sano Y, Matsumoto S, Urasaki T, Tamiya T, Tanaka H, Ito M, Miura Y, Numao N, Matsuoka Y, Koga F, Yonese J, Fujii Y. PMID: 42559798 [PubMed - indexed for MEDLINE]
	Mechanical stress, metabolic reprogramming and stromal remodeling: an emerging paradigm in the bladder cancer mechano-micro-environment. Front Genet Dong X, Chen Z, Chen Y, Xiao Z, Zhang J, Li Y, Du H. PMID: 42559655 [PubMed]
	Testing for Causal Association Between Serum Urate, Gout, and Prostatic Cancer in European Males. Gout Urate Cryst Depos Dis Chandrupatla S, Sumpter N, Takei R, Merriman TR, Singh J. PMID: 42559566 [PubMed]
	Structure-based redesign enables clinical translation of CAIX-targeted theranostics in clear cell renal cell carcinoma. Theranostics Xu Z, Zhou H, Dong Y, Feng D, Chen B, Li H, Yang R, Li N, Cao Y, He H, Wu H, Zhong Y, Wu H, Zhao L, Chen H, Hu K. PMID: 42559379 [PubMed - indexed for MEDLINE]
	PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience. Theranostics Eder AC, Omrane MA, Matthias J, Stadlbauer S, Roscher M, Michalski K, Schick MA, Wielenberg CF, Bronsert P, Gratzke C, Freitag M, Kopka K, Eder M, Meyer PT, Jilg CA, Ruf J. PMID: 42559208 [PubMed - indexed for MEDLINE]
	Decoding the temporal dimension of innate immunity in intravesical BCG therapy. Front Immunol Diao X, Che B, Zhai J, Shao B, Tang K. PMID: 42559128 [PubMed - indexed for MEDLINE]
	Leveraging MRI to reduce overtreatment in lowâ€‘grade prostate cancer: a retrospective singleâ€‘centre cohort study. Ther Adv Urol Skrobisz K, Miszewski K, Marczak B, Miszewska L, Kulski J, Matuszewski M. PMID: 42558974 [PubMed]
	Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm. Front Oncol Dai C, Zhang B, Deng Q, Feng J. PMID: 42558352 [PubMed]
	Tumor fat composition predicts response to everolimus and supports low-dose therapy in TSC-associated renal angiomyolipomas: a multicenter prospective study. Front Oncol Gao K, Duan Y, Ren B, Guo B, Su R, Gu H, Chen F, Zhang C, Wu G, Ni J. PMID: 42558341 [PubMed]
	Artificial intelligence in the early diagnosis of prostate cancer: from multimodal imaging to liquid biopsy. Front Oncol Xie J, Yin Z, Gao R, Qiu Z, Zhou Q. PMID: 42558280 [PubMed]
	Efficacy of Medical Interventions for Erectile Dysfunction after Prostate Cancer Treatment: A Systematic Review and Network Meta-Analysis. World J Mens Health Eshetie S, Ejekpokpo O, Charlick M, Tiruye T, Jay A, Higgs B, Shepherd A, Beckmann K. PMID: 42557727 [PubMed - as supplied by publisher]
	Bibliometric analysis of renal function preservation in robot-assisted partial nephrectomy: research trends, functional outcomes, and CKD-related perspectives. J Robot Surg Niu H, Xu C, Huang L, Tian Z, Man J, Yang L, Wang J. PMID: 42557524 [PubMed - indexed for MEDLINE]
	Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group. Nat Rev Urol Hensley PJ, Teoh JYC, Li R, Gupta S, Bukavina L, Mouw KW, Lobo N, Maiorano BA, Tan WS, Agarwal P, Al-Ahmadie HA, Bivalacqua TJ, Cheng L, Flaig TW, Guo CC, Horowitz A, Kassouf W, Kates MR, Konety BR, Kukreja JB, Lotan Y, McConkey DJ, Mertens LS, Mir MC, Moschini M, Necchi A, Oualla K, Packiam VT, Schmidt B, Buckley RJ, Kamat AM. PMID: 42557383 [PubMed - as supplied by publisher]
	Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort. Urol Oncol Monaco A, Koh S, Guo A, Garcia RS, Ellis T, Palasi S, Lawen T, da Silva RD, Gregg JR. PMID: 42557189 [PubMed - as supplied by publisher]
	Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update. Eur Urol Focus Privé BM, Oprea-Lager DE, Muselaers CHJ, Timmermans B, van Oort IM, Mehra N, Michiel Sedelaar JP, Vrachimis A, Noordzij W, Nagarajah J. PMID: 42557180 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin (BCG) with or without Immune Checkpoint Blockade in BCG-NaÃ¯ve High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis. Crit Rev Oncol Hematol Saâd MA, Antari A, Taleb I, El Omri S, Traoré H, Chahbounia I, Sella I, Poudiougou A, Sano FD, Omri L, Elm'hadi C, Lamine S, Mokhlis MA, Aalaoui L, Debbagh A, Khmamouche MR, Slimani KA, Sbitti Y, Mahfoud T, Errihani H, Tanz R. PMID: 42556596 [PubMed - as supplied by publisher]
	Effectiveness and safety of hormonal doublet therapy in metastatic hormone-sensitive prostate cancer: A multicenter real-world study. Actas Urol Esp (Engl Ed) Guedes Oliva P, Pérez-Fentes D, De Pablos-Rodríguez P, Bardella-Altarriba C, Díaz-Pedrouzo A, Abuin-García J, Vera-Ballesteros FJ, Abella-Serra A, Ribera-Díaz D, Martínez-Corral ME, Gómez-Ferrer Á, Picola-Brau N, Martínez-Breijo S, Costa-Planells M, López-Abad A, García-Puche M, Jiménez Marrero P, Martínez Corral R. PMID: 42551521 [PubMed - as supplied by publisher]
	Prognostic clinical indicators in patients with metastatic castration-resistant prostate cancer treated with radium-223 plus enzalutamide: Data from patients in J-RAP-BSI trial. Hell J Nucl Med Kitajima K, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Yamamoto S, Narita M, Yamakado K. PMID: 42555489 [PubMed - as supplied by publisher]
	"Renal cell carcinoma, not otherwise specified" is not a sufficient diagnostic classification. Virchows Arch Yildirim NA, Bayrak BY, Cheng L, Akgul M. PMID: 42554860 [PubMed - as supplied by publisher]
	MRI Standards for Prostate Cancer Screening in the PRISM Consensus Recommendations. AJR Am J Roentgenol Ponsiglione A, Brembilla G. PMID: 42554687 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190279

Page 1 of 9514



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy